![Hon Chuen Wei](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hon Chuen Wei
Fondateur chez
Rimasia Capital Partners LP
Profil
Mr. Hon Chuen Wei is Managing Partner at RimAsia Capital Partners.
He is on the Board of Directors at NeoStem, Inc.
Mr. Wei was previously employed as a Managing Director by Crimson Asia Capital Partners Corp.
He also served on the board at China Biopharmaceuticals Holdings, Inc.
He received his undergraduate degree from Amherst College and an MBA from the University of Pennsylvania.
Postes actifs de Hon Chuen Wei
| Sociétés | Poste | Début |
|---|---|---|
Rimasia Capital Partners GP Ltd. | Directeur/Membre du Conseil | - |
Rimasia Capital Partners LP
 Rimasia Capital Partners LP Investment ManagersFinance Acts as Private Equity Fund | Fondateur | - |
Anciens postes connus de Hon Chuen Wei
| Sociétés | Poste | Fin |
|---|---|---|
The Nature Conservancy, Inc.
 The Nature Conservancy, Inc. Miscellaneous Commercial ServicesCommercial Services Provides wildlife protection programs | Directeur/Membre du Conseil | 01/03/2022 |
RimAsia Capital Partners (Hong Kong) Ltd.
 RimAsia Capital Partners (Hong Kong) Ltd. Investment ManagersFinance RimAsia Capital Partners invests in mid-market companies located in Asia with revenues of USD 50 to USD 250 million with an investment size of USD 5 to USD 30 million. The firm targets companies operating in the fields of agriculture-based businesses, consumer products & services, financial services, infrastructure services, manufacturing, natural resources, and technology sectors. It provides mezzanine and debt financing for pre-IPO, restructuring, structured financings, and expansion stage capital requirements. It also takes controlling equity stakes. | Fondateur | 01/01/2018 |
China Biopharmaceuticals Holdings, Inc.
 China Biopharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and researches molecule pharmaceutical products | Directeur/Membre du Conseil | 13/03/2007 |
Asian Infrastructure Fund
 Asian Infrastructure Fund Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Fondateur | - |
Gilbert Global Equity Partners LLC
 Gilbert Global Equity Partners LLC Investment ManagersFinance Gilbert Global is an institutional investment firm that makes private equity and equity-related investments in both public and private companies around the world. They make Individual controlling or non-controlling direct investments generally ranging from $20 million to $150 million. Their portfolio companies span a range of industries, including telecommunications equipment and services, financial and business services and traditional industrial and consumer-related businesses. They participate in a variety of transaction types including (1) growth companies formed around outstanding management teams with unique products and/or services (2) privatizations of franchises (3) strategic alliances with entities that can be used as acquisition and/or consolidation vehicles (4) established businesses that produce high levels of cash flow to repay acquisition indebtedness and (5) operational turnarounds of distressed, underperforming companies with overleveraged capital structures. | Corporate Officer/Principal | - |
Formation de Hon Chuen Wei
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Asian Infrastructure Fund
Asian Infrastructure Fund Investment Trusts/Mutual FundsMiscellaneous Closed-End Investment Fund/Investment Trust | Miscellaneous |
Rimasia Capital Partners GP Ltd. | |
Rimasia Capital Partners LP
Rimasia Capital Partners LP Investment ManagersFinance Acts as Private Equity Fund | Finance |
Gilbert Global Equity Partners LLC
Gilbert Global Equity Partners LLC Investment ManagersFinance Gilbert Global is an institutional investment firm that makes private equity and equity-related investments in both public and private companies around the world. They make Individual controlling or non-controlling direct investments generally ranging from $20 million to $150 million. Their portfolio companies span a range of industries, including telecommunications equipment and services, financial and business services and traditional industrial and consumer-related businesses. They participate in a variety of transaction types including (1) growth companies formed around outstanding management teams with unique products and/or services (2) privatizations of franchises (3) strategic alliances with entities that can be used as acquisition and/or consolidation vehicles (4) established businesses that produce high levels of cash flow to repay acquisition indebtedness and (5) operational turnarounds of distressed, underperforming companies with overleveraged capital structures. | Finance |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Biopharmaceuticals Holdings, Inc.
China Biopharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures, distributes and researches molecule pharmaceutical products | Health Technology |
RimAsia Capital Partners (Hong Kong) Ltd.
RimAsia Capital Partners (Hong Kong) Ltd. Investment ManagersFinance RimAsia Capital Partners invests in mid-market companies located in Asia with revenues of USD 50 to USD 250 million with an investment size of USD 5 to USD 30 million. The firm targets companies operating in the fields of agriculture-based businesses, consumer products & services, financial services, infrastructure services, manufacturing, natural resources, and technology sectors. It provides mezzanine and debt financing for pre-IPO, restructuring, structured financings, and expansion stage capital requirements. It also takes controlling equity stakes. | Finance |
Caladrius Biosciences, Inc.
 Caladrius Biosciences, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes cellular therapies products | Health Technology |
The Nature Conservancy, Inc.
The Nature Conservancy, Inc. Miscellaneous Commercial ServicesCommercial Services Provides wildlife protection programs | Commercial Services |
Ismay New Media Ltd.
 Ismay New Media Ltd. Publishing: Books/MagazinesConsumer Services Publishes newspapers, magazines, and tabloids | Consumer Services |
Crimson Asia Capital Partners Corp.
 Crimson Asia Capital Partners Corp. Investment ManagersFinance Functions as private equity fund | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
